Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drugs, Chinese Herbal | 4 | 2021 | 146 | 2.070 |
Why?
|
Medicine, Kampo | 3 | 2021 | 4 | 1.610 |
Why?
|
Anemia, Aplastic | 9 | 2021 | 231 | 1.430 |
Why?
|
Bone Marrow Diseases | 3 | 2023 | 234 | 1.040 |
Why?
|
Cystitis | 2 | 2014 | 96 | 0.850 |
Why?
|
Dyskeratosis Congenita | 1 | 2023 | 70 | 0.830 |
Why?
|
Graft vs Host Disease | 7 | 2023 | 3049 | 0.830 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2023 | 84 | 0.820 |
Why?
|
Lipomatosis | 1 | 2023 | 112 | 0.810 |
Why?
|
Hematopoietic Stem Cell Transplantation | 9 | 2023 | 5716 | 0.780 |
Why?
|
Plakins | 1 | 2021 | 4 | 0.770 |
Why?
|
Hematologic Diseases | 2 | 2023 | 498 | 0.760 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2021 | 64 | 0.730 |
Why?
|
Crying | 1 | 2021 | 37 | 0.720 |
Why?
|
Parasomnias | 1 | 2021 | 27 | 0.720 |
Why?
|
Pancytopenia | 2 | 2023 | 102 | 0.630 |
Why?
|
Alopecia Areata | 1 | 2021 | 130 | 0.620 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 348 | 0.540 |
Why?
|
Acupuncture Therapy | 1 | 2021 | 485 | 0.540 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1604 | 0.530 |
Why?
|
Hematuria | 2 | 2014 | 232 | 0.520 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 3 | 2021 | 24 | 0.510 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2023 | 355 | 0.510 |
Why?
|
Adenovirus Infections, Human | 1 | 2015 | 76 | 0.480 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2014 | 146 | 0.440 |
Why?
|
Hepatitis | 1 | 2015 | 226 | 0.440 |
Why?
|
Autoantibodies | 1 | 2021 | 2114 | 0.400 |
Why?
|
Fusarium | 1 | 2012 | 50 | 0.400 |
Why?
|
Tumor Virus Infections | 1 | 2014 | 437 | 0.380 |
Why?
|
Epoprostenol | 1 | 2012 | 246 | 0.380 |
Why?
|
Lung Transplantation | 1 | 2021 | 1310 | 0.380 |
Why?
|
Hemoglobinuria, Paroxysmal | 3 | 2017 | 96 | 0.380 |
Why?
|
DNA, Viral | 2 | 2015 | 2201 | 0.380 |
Why?
|
Viremia | 1 | 2014 | 726 | 0.380 |
Why?
|
Adenoviridae | 1 | 2015 | 1092 | 0.370 |
Why?
|
Phytotherapy | 1 | 2012 | 298 | 0.350 |
Why?
|
Sulfones | 1 | 2012 | 447 | 0.340 |
Why?
|
Hematologic Neoplasms | 3 | 2019 | 1907 | 0.340 |
Why?
|
Antilymphocyte Serum | 3 | 2023 | 490 | 0.320 |
Why?
|
Vasodilator Agents | 1 | 2012 | 988 | 0.300 |
Why?
|
Cytokines | 1 | 2023 | 7446 | 0.300 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 1559 | 0.280 |
Why?
|
Eosinophilia | 1 | 2012 | 554 | 0.280 |
Why?
|
Child | 28 | 2023 | 80771 | 0.280 |
Why?
|
Antifungal Agents | 1 | 2012 | 760 | 0.280 |
Why?
|
Bone Marrow | 2 | 2014 | 2926 | 0.280 |
Why?
|
Japan | 5 | 2020 | 1418 | 0.270 |
Why?
|
Triazoles | 1 | 2012 | 903 | 0.270 |
Why?
|
Arthritis | 1 | 2012 | 684 | 0.270 |
Why?
|
Cord Blood Stem Cell Transplantation | 3 | 2021 | 305 | 0.270 |
Why?
|
Infant | 19 | 2021 | 36485 | 0.260 |
Why?
|
Urinary Bladder | 1 | 2012 | 1155 | 0.260 |
Why?
|
Antiviral Agents | 2 | 2015 | 3070 | 0.250 |
Why?
|
Pyrimidines | 2 | 2021 | 3044 | 0.250 |
Why?
|
Child, Preschool | 19 | 2022 | 42606 | 0.240 |
Why?
|
Leukemia | 1 | 2012 | 1518 | 0.230 |
Why?
|
Child, Hospitalized | 2 | 2023 | 182 | 0.230 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4247 | 0.220 |
Why?
|
Signal Recognition Particle | 1 | 2023 | 45 | 0.220 |
Why?
|
Registries | 2 | 2019 | 8351 | 0.210 |
Why?
|
Repressor Proteins | 2 | 2016 | 2979 | 0.200 |
Why?
|
Piperazines | 1 | 2012 | 2548 | 0.200 |
Why?
|
Adolescent | 19 | 2021 | 89046 | 0.190 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2800 | 0.190 |
Why?
|
Bone Marrow Transplantation | 3 | 2023 | 2710 | 0.190 |
Why?
|
Telomere | 3 | 2021 | 943 | 0.180 |
Why?
|
Hospitalization | 1 | 2021 | 10815 | 0.180 |
Why?
|
Hemorrhage | 1 | 2012 | 3464 | 0.170 |
Why?
|
Janus Kinase 3 | 1 | 2020 | 75 | 0.170 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6067 | 0.170 |
Why?
|
Transplantation Conditioning | 3 | 2022 | 1601 | 0.160 |
Why?
|
Interferon-alpha | 1 | 2023 | 909 | 0.160 |
Why?
|
Catheter-Related Infections | 1 | 2022 | 277 | 0.160 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1608 | 0.160 |
Why?
|
Humans | 46 | 2023 | 767040 | 0.160 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 1 | 2018 | 15 | 0.150 |
Why?
|
Catheterization, Peripheral | 1 | 2022 | 346 | 0.150 |
Why?
|
Mutation | 7 | 2023 | 30211 | 0.150 |
Why?
|
Cysteine Endopeptidases | 1 | 2021 | 542 | 0.150 |
Why?
|
Thrombosis | 1 | 2012 | 2954 | 0.150 |
Why?
|
Neoplasms | 3 | 2023 | 22350 | 0.150 |
Why?
|
Dermatan Sulfate | 1 | 2017 | 43 | 0.150 |
Why?
|
Aneurysm, Infected | 1 | 2018 | 81 | 0.150 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2018 | 71 | 0.150 |
Why?
|
Chondroitin Sulfates | 1 | 2017 | 174 | 0.140 |
Why?
|
Catheterization, Central Venous | 1 | 2022 | 537 | 0.140 |
Why?
|
Pericarditis | 1 | 2018 | 136 | 0.140 |
Why?
|
Immunosuppressive Agents | 3 | 2021 | 4210 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 892 | 0.130 |
Why?
|
Heparitin Sulfate | 1 | 2017 | 223 | 0.130 |
Why?
|
Pericardial Effusion | 1 | 2018 | 246 | 0.130 |
Why?
|
Transplantation, Homologous | 4 | 2023 | 4838 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3626 | 0.130 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2015 | 18 | 0.130 |
Why?
|
Viral Load | 2 | 2015 | 3385 | 0.130 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2015 | 89 | 0.130 |
Why?
|
Aspergillus | 1 | 2015 | 94 | 0.120 |
Why?
|
Myelodysplastic Syndromes | 2 | 2015 | 1399 | 0.120 |
Why?
|
Calreticulin | 1 | 2016 | 115 | 0.120 |
Why?
|
Male | 26 | 2021 | 364203 | 0.120 |
Why?
|
Medicine, East Asian Traditional | 1 | 2014 | 17 | 0.120 |
Why?
|
Thrombocythemia, Essential | 1 | 2016 | 114 | 0.120 |
Why?
|
Receptors, Thrombopoietin | 1 | 2016 | 159 | 0.120 |
Why?
|
GATA2 Transcription Factor | 1 | 2015 | 158 | 0.120 |
Why?
|
Echocardiography | 2 | 2021 | 5042 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1741 | 0.120 |
Why?
|
DiGeorge Syndrome | 1 | 2016 | 187 | 0.120 |
Why?
|
DNA Transposable Elements | 1 | 2018 | 763 | 0.120 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 230 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2021 | 2592 | 0.110 |
Why?
|
BK Virus | 1 | 2014 | 120 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2022 | 1266 | 0.110 |
Why?
|
Thrombopoietin | 1 | 2015 | 225 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2887 | 0.110 |
Why?
|
Janus Kinase 2 | 1 | 2016 | 561 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2023 | 81659 | 0.100 |
Why?
|
Piperidines | 1 | 2021 | 1667 | 0.100 |
Why?
|
Natural Killer T-Cells | 1 | 2015 | 319 | 0.100 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2018 | 707 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 549 | 0.100 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2012 | 228 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1012 | 0.090 |
Why?
|
Histocytochemistry | 1 | 2012 | 697 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2056 | 0.090 |
Why?
|
Cytomegalovirus | 1 | 2015 | 751 | 0.090 |
Why?
|
Injections, Intra-Articular | 1 | 2012 | 284 | 0.090 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2012 | 341 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10254 | 0.080 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2014 | 245 | 0.080 |
Why?
|
Interleukin-17 | 1 | 2015 | 922 | 0.080 |
Why?
|
Female | 21 | 2021 | 396660 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 667 | 0.080 |
Why?
|
Virus Diseases | 1 | 2015 | 722 | 0.080 |
Why?
|
Fetal Blood | 1 | 2016 | 1361 | 0.080 |
Why?
|
Purines | 1 | 2012 | 614 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2568 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1596 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8535 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2015 | 616 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2255 | 0.080 |
Why?
|
Genetic Testing | 2 | 2018 | 3591 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3667 | 0.070 |
Why?
|
Infant, Newborn | 5 | 2021 | 26396 | 0.070 |
Why?
|
Microscopy | 1 | 2012 | 903 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2020 | 4925 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2012 | 862 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1391 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9362 | 0.070 |
Why?
|
Lymphocytes | 1 | 2014 | 2605 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2021 | 65295 | 0.060 |
Why?
|
Drug-Eluting Stents | 1 | 2011 | 681 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5794 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1721 | 0.060 |
Why?
|
Sirolimus | 1 | 2011 | 1539 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3599 | 0.060 |
Why?
|
Paclitaxel | 1 | 2011 | 1728 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2227 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10076 | 0.050 |
Why?
|
Leukocyte Count | 2 | 2018 | 1606 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 24299 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4498 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10455 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4854 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9532 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4648 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5693 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2131 | 0.050 |
Why?
|
Etoposide | 1 | 2022 | 639 | 0.040 |
Why?
|
Disease Progression | 2 | 2014 | 13646 | 0.040 |
Why?
|
Melphalan | 1 | 2022 | 421 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4114 | 0.040 |
Why?
|
Suppuration | 1 | 2018 | 60 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2021 | 793 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 644 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 790 | 0.040 |
Why?
|
Prognosis | 5 | 2021 | 29963 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1442 | 0.040 |
Why?
|
Skin | 1 | 2012 | 4499 | 0.040 |
Why?
|
Camptothecin | 1 | 2022 | 599 | 0.040 |
Why?
|
Prospective Studies | 1 | 2023 | 54886 | 0.040 |
Why?
|
Pedigree | 2 | 2015 | 4539 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1334 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12986 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2016 | 154 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1743 | 0.030 |
Why?
|
Time Factors | 2 | 2016 | 40154 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1864 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1916 | 0.030 |
Why?
|
Risk Factors | 6 | 2022 | 74886 | 0.030 |
Why?
|
Retroviridae | 1 | 2018 | 846 | 0.030 |
Why?
|
DNA Methylation | 2 | 2021 | 4426 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4780 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39317 | 0.030 |
Why?
|
Lentivirus | 1 | 2018 | 518 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1885 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 719 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2016 | 748 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2016 | 483 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3618 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2018 | 764 | 0.030 |
Why?
|
Drainage | 1 | 2018 | 1183 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12823 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2018 | 1110 | 0.020 |
Why?
|
Mosaicism | 1 | 2015 | 480 | 0.020 |
Why?
|
Adult | 3 | 2021 | 223317 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2016 | 712 | 0.020 |
Why?
|
Platelet Count | 1 | 2014 | 784 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11513 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1836 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9410 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2531 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20741 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4751 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13650 | 0.020 |
Why?
|
Dexamethasone | 1 | 2016 | 1963 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6106 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2040 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3804 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59980 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4280 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3851 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10582 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6844 | 0.020 |
Why?
|
Tissue Donors | 1 | 2015 | 2387 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2744 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2105 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10092 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2824 | 0.010 |
Why?
|
Family | 1 | 2015 | 3210 | 0.010 |
Why?
|
Aged | 4 | 2021 | 171319 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2016 | 4787 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15925 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8504 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12069 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21526 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11872 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7868 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7469 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9606 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17097 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12790 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18401 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5345 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15424 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 223233 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12158 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 18063 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2012 | 59548 | 0.000 |
Why?
|
Animals | 1 | 2015 | 168965 | 0.000 |
Why?
|